Prenatal alcohol and stroke susceptibility in the aging adult with FASD
患有 FASD 的老年人的产前酒精和中风易感性
基本信息
- 批准号:10172800
- 负责人:
- 金额:$ 33.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-02 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccidentsAcuteAddressAdultAffectAgeAgingAlcohol abuseAlcoholismAlcoholsAnimal ModelAnimalsBehaviorBlood - brain barrier anatomyBlood VesselsBrainBrain InjuriesCardiovascular DiseasesCardiovascular systemCaringCephalicChromatinCollaborationsDataDiseaseDisease OutcomeEpigenetic ProcessExhibitsFemaleFetal Alcohol ExposureFetal Alcohol Spectrum DisorderFetal alcohol effectsFirst Pregnancy TrimesterGoalsGuidelinesHDAC4 geneHealthHeart HypertrophyHepaticHistone Deacetylase InhibitorHypertensionIGF1 geneImpairmentIndividualIndustryInfarctionInflammationInstitutesIschemiaIschemic StrokeKidney FailureKnowledgeLifeLiverLongevityMediatingMental HealthMetabolic DiseasesMicroRNAsMiddle Cerebral Artery OcclusionMissionModelingMusOnset of illnessOutcomeOutcome StudyPathway interactionsPhasePredispositionPremature MortalityPublishingRattusRecording of previous eventsRecoveryRepressionResearchResearch PersonnelRiskRisk FactorsSensorimotor functionsSignal PathwaySignal TransductionSodium ButyrateSomatomedinsStrokeSupplementationSurgical suturesTeenagersTestingTissue SurvivalTranslationsadverse outcomeage relatedagedalcohol exposurealcohol preventionalcohol related consequencesbaseblood-brain barrier permeabilizationcerebrovascularclinical caredisabilityexperiencehypoperfusionimprovedinnovationmalemiddle agemiddle cerebral arterymouse modelneurological recoverypeptide hormonepost strokeprenatalstroke incidencestroke outcomestroke therapyvasoconstrictionvirtualyoung adult
项目摘要
Project(Summary(
Fetal Alcohol Spectrum Disorders (FASD) result in life-long systemic disabilities that contribute to disease and
premature mortality in FASD adults. We recently found that prenatal alcohol-exposure (PAE) led to long-term
deficits in cranially-directed vascular function in aging mice. PAE also diminished neurological recovery in
young adult mice following cerebrovascular ischemic stroke. Preliminary data indicate that middle-aged PAE
animals experience larger stroke infarcts compared to age-matched controls or young PAE adults. Moreover,
reduced levels of the peptide hormone, IGF1, and epigenetic re-programming of IGF pathways contribute to
ischemia-induced brain damage and disability, while intracranial IGF1 delivery after stroke improves tissue
survival and behavior. Therefore, we hypothesize that ‘PAE accelerates the age-dependent increase in brain
vulnerability to ischemic stroke by epigenetically programming IGF1 signaling pathways’’. We plan to assess
effects of PAE on brain adaptation to ischemia in aging male and female adults in rat models, and consistent
with stroke research guidelines, use two models for ischemic stroke by intraluminal suture-occlusion and by
endtothelin-1-mediated vasoconstriction of the middle cerebral artery.
Aim 1 will determine the extent to which PAE influences brain damage, sensorimotor impairment, and blood
brain barrier (BBB) permeability, in aging adults following ischemia. Our working hypothesis is that the middle-
aged PAE brain will exhibit a larger infarct volume following ischemia, compared to age-matched controls, and
comparable to the aged non-PAE adult brain. Middle-aged and aged PAE animals will also exhibit increased
sensorimotor impairment, accompanied by prolonged BBB permeability following an ischemic episode
compared to age-matched, non-PAE controls. Aim 2 will assess the contribution of PAE to aging-related
epigenetic reprogramming of IGF1 pathways. Our working hypothesis is that PAE epigenetically reprograms
liver and brain resulting in aging-related loss of IGF1 in adulthood. We expect that PAE will result in chromatin
silencing or miRNA-mediated translation-repression of IGF1 signaling. Aim 3 will determine the impact of
exogenous IGF1, or epigenetic stimulators of hepatic or brain IGF1, on ischemia outcomes in PAE adults. Our
working hypothesis is that IGF1 supplementation after ischemia will ameliorate effects of PAE on the BBB,
infarct volume, and sensorimotor function in aging animals. We will test the extent to which effects of PAE on
stroke-induced impairment are ameliorated by post-stroke treatment with IGF1, or with agents that promote
IGF function, like sodium butyrate, a histone deacetylase inhibitor, and an antagomir to the microRNA Let7.
This proposal tests an innovative hypothesis that PAE increases risk for adverse outcomes due to adult-onset
disease, in an experimentally rigorous way. It is significant because it addresses a critical knowledge gap
about brain vulnerability in aging adults with FASD. The investigators have a history of collaboration, and
bring complementary expertise to studies that will inform clinical care of adults with FASD.
项目(摘要)
胎儿酒精谱系障碍(FASD)导致终身全身性残疾,导致疾病和
FASD成人的过早死亡率。我们最近发现,产前酒精暴露(PAE)导致长期的
老年小鼠颅向血管功能的缺陷。PAE还减少了神经恢复,
年轻成年小鼠脑血管缺血性中风后。初步数据显示,中年PAE
与年龄匹配的对照组或年轻的PAE成年人相比,动物经历更大的中风梗塞。此外,委员会认为,
肽激素、IGF 1水平降低和IGF途径的表观遗传重编程有助于
缺血引起的脑损伤和残疾,而脑卒中后颅内IGF 1输送可改善组织
生存和行为。因此,我们假设PAE加速了大脑中年龄依赖性的增加,
通过表观遗传学编程IGF 1信号通路对缺血性中风的脆弱性”。我们计划评估
PAE对老年男性和女性成年大鼠模型脑缺血适应性的影响,
根据卒中研究指南,使用两种缺血性卒中模型,即腔内缝合闭塞模型和
内皮素-1介导的大脑中动脉血管收缩。
目的1将确定PAE影响脑损伤、感觉运动障碍和血液循环的程度。
脑屏障(BBB)通透性,在老年人缺血后。我们的假设是中间的-
与年龄匹配的对照组相比,老年PAE脑在缺血后将表现出更大的梗死体积,
与老年非PAE成人大脑相当。中年和老年PAE动物也将表现出增加的
感觉运动障碍,伴随缺血发作后BBB通透性延长
与年龄匹配的非PAE对照组相比。目标2将评估PAE对衰老相关疾病的贡献。
IGF 1途径的表观遗传重编程。我们的假设是PAE在表观遗传学上
肝脏和大脑,导致成年期IGF 1的衰老相关损失。我们预计PAE会导致染色质
沉默或miRNA介导的IGF 1信号传导的抑制。目标3将决定
外源性IGF 1或肝或脑IGF 1的表观遗传刺激物对PAE成人缺血结局的影响。我们
工作假设是缺血后补充IGF 1将改善PAE对BBB的影响,
梗死体积和感觉运动功能。我们将测试CAE对人体的影响程度
中风后用IGF 1治疗或用促进中风后损伤的药物治疗可改善中风引起的损伤。
IGF的功能,如丁酸钠,组蛋白脱乙酰酶抑制剂,和microRNA Let 7的抑制剂。
该提案检验了一个创新假设,即PAE增加了成人发病所致不良结局的风险。
疾病,在实验严格的方式。它意义重大,因为它解决了一个关键的知识差距
关于患有FASD的老年人大脑的脆弱性。调查人员有合作的历史,
为研究提供补充专业知识,为FASD成人的临床护理提供信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rajesh C Miranda其他文献
Rajesh C Miranda的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rajesh C Miranda', 18)}}的其他基金
Impact of Prenatal alcohol on Alzheimer's disease related pathology and cognitive impairment
产前酒精对阿尔茨海默病相关病理和认知障碍的影响
- 批准号:
10387300 - 财政年份:2022
- 资助金额:
$ 33.41万 - 项目类别:
Impact of Prenatal alcohol on Alzheimer's disease related pathology and cognitive impairment
产前酒精对阿尔茨海默病相关病理和认知障碍的影响
- 批准号:
10570173 - 财政年份:2022
- 资助金额:
$ 33.41万 - 项目类别:
Prenatal alcohol and stroke susceptibility in the aging adult with FASD
患有 FASD 的老年人的产前酒精和中风易感性
- 批准号:
10396634 - 财政年份:2018
- 资助金额:
$ 33.41万 - 项目类别:
Prenatal alcohol and stroke susceptibility in the aging adult with FASD
患有 FASD 的老年人的产前酒精和中风易感性
- 批准号:
9915821 - 财政年份:2018
- 资助金额:
$ 33.41万 - 项目类别:
Prenatal microRNA neuro-therapeutics for fetal alcohol exposure
针对胎儿酒精暴露的产前 microRNA 神经疗法
- 批准号:
9240564 - 财政年份:2016
- 资助金额:
$ 33.41万 - 项目类别:
Prenatal microRNA neuro-therapeutics for fetal alcohol exposure
针对胎儿酒精暴露的产前 microRNA 神经疗法
- 批准号:
9044875 - 财政年份:2016
- 资助金额:
$ 33.41万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 33.41万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 33.41万 - 项目类别:
Standard Grant